Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) – Financial and Strategic SWOT Analysis Review – new company profile report – Transworld News

It offers quinolone drugs, cephalosporin drugs, drugs for cardio-cerebral-vascular diseases, traditional chinese herbal medicines and other drugs. Jingxin Pharma’s products include APIs, comprising levofloxacin hemihydrate, ciprofloxacin HCL, ofloxacin …

Leave a Reply

Your email address will not be published.

*